Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Ventricular Assist Device Market Forecast: What Value Will The Market Reach By 2030?
The ventricular assist device market has experienced significant expansion in recent times. Projections indicate it will expand from $2.37 billion in 2025 to $2.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.3%. This historical growth can be linked to factors such as the rising incidence of end-stage heart failure, the scarcity of donor hearts, continuous improvements in mechanical circulatory support technologies, an increase in the clinical adoption of LVAD therapy, and better surgical results.
The ventricular assist device market is projected to experience substantial expansion in the coming years. It will grow to $4.34 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. This projected increase is fueled by factors such as an expanding elderly demographic facing heart conditions, the increasing utilization of prolonged mechanical assistance, improvements in device longevity through technology, the proliferation of patient monitoring solutions at home, and heightened investment in sophisticated cardiac care facilities. Key developments anticipated during this period encompass innovations in compact implantable pump designs, a wider embrace of continuous-flow devices, the incorporation of remote patient oversight features, the use of enhanced biocompatible substances, and the broader application of destination therapy.
Get A Free Sample Report With In-Depth Market Insights:
Ventricular Assist Device Market Demand Drivers Opening New Revenue Streams
The rising occurrence of cardiovascular conditions is fueling the expansion of the ventricular assist device market moving forward. These heart ailments stem from factors such as elevated blood pressure, smoking, high cholesterol, and sedentary lifestyles. Furthermore, the growing incidence of cardiovascular disorders can be attributed to non-communicable conditions like diabetes, chronic respiratory diseases, and hypertension-related heart attacks. This substantial rise in cardiovascular conditions is projected to escalate the need for ventricular assist devices, given their crucial role as a support system for critically ill heart patients. For example, data from the US-based public health institute, the Centers for Disease Control and Prevention, in October 2024, showed that in 2023, approximately 1 out of every 6 cardiovascular disease fatalities occurred in adults younger than 65 years old, with a total of 919,032 people dying from these diseases, accounting for 1 in every 3 deaths. Consequently, the increasing prevalence of cardiovascular disorders is anticipated to significantly drive demand within the ventricular assist device market.
Ventricular Assist Device Market Segmentation And Category Overview
The ventricular assist device market covered in this report is segmented –
1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs)
2) By Flow Mechanism: Pulsatile Flow, Continuous Flow
3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices
4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy
5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres
Subsegments:
1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs
2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs
3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs
Ventricular Assist Device Market Trends Powering Strategic Industry Growth
Key companies active in the ventricular assist device (VAD) market are concentrating on technological advancements, such as laser-welding technology, to decrease the size and weight of implantable devices, improve biocompatibility, and strengthen structural integrity. Utilizing precise laser welding allows manufacturers to produce lighter, more compact pumps without sacrificing durability, ultimately making these devices more fitting for a wider array of patients and improving long-term outcomes. For example, in March 2024, Evaheart Medical, an artificial heart company from China, launched its EVA-Pulsar ventricular assist device, which weighs only 262 grams, achieved through laser-welding technology. This light design helps to closely replicate natural pulse pressure (20–30 mmHg) and supports a more physiological cardiac output, thereby lessening the risks linked to continuous-flow devices. The EVA-Pulsar has also received regulatory approval in Japan, and clinical trials are currently ongoing in the U.S., highlighting its global potential.
Ventricular Assist Device Market Key Players Shaping Industry Direction
Major companies operating in the ventricular assist device market are Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC, Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd
View The Full Ventricular Assist Device Market Report:
Ventricular Assist Device Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the ventricular assist device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
